Company search

  1. Home
  2. Company search

Company search

KOBE Life Science Cluster Company List

Business Expansion
on Kobe's Port Island

339

companies

as of February 28, 2026

Companies are divided into categories by their major business field on Kobe Port Island. In the case they have other business fields, it is shown in the minor field.» List of KBIC companies(PDF)

≫ StartupsStartups Company List

Search by Company name or Keyword

Entities are classified mainly by their business activities in the South area of KOBE Port Island.

Business sector search results

1～ 9of Results 9

Re-search in Business sector

Entities are classified mainly by their business activities in the South area of KOBE Port Island.

Location search results Business Support Center for Biomedical Research Activities(BMA)

1～ 9of Results 9

Re-search in Location

AlliedCel Corporation

Major field： Regenerative Medicine

Miner field： Drug Discovery

Miner field： Production of Drugs and Quasi Drugs

BioView, Inc.

Major field： Contract Research

Miner field： CRO

Drug development and research business by using MRI and PET

Overview

We are Japan’s first CRO utilizing experimental MRI and PET contributing to saving time, reduction in cost and the number of laboratory animals by making good use of our experience and expertise in pharmacological imaging as below, and also conducts MRI-safety evaluation.

Product / Service / PR

    BioView contributes to saving time, reduction in cost and the number of laboratory animals by making good use of our MRI expertise and an analytical technology of images. Additionally, our method is capable of becoming a breakthrough while usual biological methods can not evaluate a new pharmaceutical concept.
    ・Experimental MRI ・Anatomical and functional Imaging
    ・Molecular imaging ・T1 and T2 weighted imaging
    ・Diffusion MRI ・MR safety test by ASTM
    ・Pacemaker, etc.
Address： 2-17-7 Iwamoto-cho, Chiyoda-ku, Tokyo, 101-0032, Japan　 （Contact Person　 Asami Masuda）
TEL： +81-3-6228-0884 FAX： +81-3-6368-4842
Web site： http://www.bioview.co.jp/ E-mail： info@bioview.co.jp

Carna Biosciences, Inc.

Major field： Drug Discovery

Miner field： Genomics

Miner field： Contract Research

Drug discovery business and drug discovery support business

Overview

Carna Biosciences, Inc. is a biotech company established in April 2003 in Kobe as a spin-off company from Japanese research unit of NV Organon and is listed on Tokyo Stock Exchange JASDAQ Growth.
We conduct research and development to discover novel kinase inhibitors and provide drug discovery supporting services based on the drug discovery platform technology that have been acquired through many years of research and development experiences.

Product / Service / PR

    Carna Biosciences is focused on the discovery and development of kinase inhibitor drugs to treat serious unmet medical needs in oncology, autoimmune and neurological diseases by inhibiting kinases that are important drivers for those diseases.
    Carna Biosciences also provides high quality kinase proteins, accurate screening and profiling services, assay kits and assay development that satisfy customer needs, and cell-based assay services, playing an important role in kinase inhibitor drug discovery conducted by global pharmaceutical companies.
Address： BMA 3F, 1-5-5, Minatojima-Minamimachi, Chuo-ku, Kobe 650-0047　 （Contact Person　 Corporate Planning）
TEL： +81-78-302-7039 FAX： +81-78-302-6665
Web site： https://www.carnabio.com/english/ E-mail： ir-team@carnabio.com

Japan Blood Products Organization

Major field： Drug Discovery

R&D of blood plasma derivares

KITAYAMA LABES CO.LTD.

Major field： Experimental Animals

Miner field： Regenerative Medicine

Miner field： Contract Research

Core Facility for Laboratory Animal Research Management

Knowledge Palette, Inc.

Major field： Regenerative Medicine

Miner field： Drug Discovery

Miner field： Genomics

Phenotypic drug discovery and cell manufacturing optimization based on whole gene expression profiling with the world’s best accuracy

Overview

We conduct (i) phenotypic drug discovery and (ii) cell manufacturing optimization using our transcriptome technology with the world’s best accuracy:
(i) As whole transcriptome can detect influences of drug treatments on the cells comprehensively, we select novel compounds with high efficacy and low toxicity, and predict the mechanism of action.
(ii) By analyzing transcriptome of cells cultured under a variety of conditions, we select optimal culture media which maximize functionality and productivity of the cells.

Product / Service / PR

    Our single-cell transcriptome technology was ranked as No.1 on both accuracy and overall scores in an international benchmarking (Mereu et al. Nat Biotechnol. 2020). The application of this technology can obtain the total gene expression profile at less than 1/10 of the cost of conventional RNA sequencing technologies. By collecting transcriptome data on a large scale, we conduct joint research with pharmaceutical companies on phenotypic drug discovery and high quality regenerative medicine.
Address： Creative Lab for innovation in Kobe 2F, 6-3-7 Minatojima　Minamimachi, Chuo-ku, Kobe-shi, Hyogo 650-0047, Japan　 （Contact Person　 Masakazu Fukuda (Representative Director & CTO)）
Web site： https://www.knowledge-palette.com/en/ E-mail： info@knowledge-palette.com

Kobe Urban Promotion Service Co.,Ltd.

Major field： Other

Leasing of R&D facilities, etc. related to medicine, bio, and health.

Senju Pharmaceutical Co., Ltd.Kobe Innovative Center

Major field： Production of Drugs and Quasi Drugs

Miner field： Drug Discovery

Development of ophthalmological drugs

Overview

Senju Pharmaceutical Co., Ltd. researches, develops, manufactures, and sells prescription drugs, mainly for ophthalmology and otolaryngology, as well as OTC products for such things as contact lens care and drugs for animals.
The Kobe Innovative Center of Senju Pharmaceutical conducts research in order to create original ophthalmic drugs by identifying the molecules responsible for ocular diseases, and additionally screens compounds from around the world for those that are effective at treating ocular diseases.

Product / Service / PR

    Senju Pharmaceutical’s mission is to improve eye health around the world and prioritize safety for our products. We have developed original, cutting edge medicines as a pioneer in ophthalmic medication.
    We perform research and development through an open-minded process collaborating with leading scientists in universities and industries worldwide.
Address： 6-4-3,Minatojima-Minamimachi,Chuo-Ku, Kobe,Hyogo 650-0047,Japan　
TEL： +81-78-777-1010 FAX： +81-78-777-1003
Web site： http://www.senju.co.jp

Shimadzu Corporation

Major field： Production of Research Equipment

Miner field： IT